ICD-10-CM Code E16.3
Increased secretion of glucagon
| ICD-10 from 2011 - 2016
Billable CodeBillable codes are sufficient justification for admission to an acute care hospital when used a principal diagnosis.
E16.3 is a billable ICD code used to specify a diagnosis of increased secretion of glucagon. A 'billable code' is detailed enough to be used to specify a medical diagnosis.
Coding Notes for E16.3 Info for medical coders on how to properly use this ICD-10 code
Inclusion TermsInclusion Terms are a list of concepts for which a specific code is used. The list of Inclusion Terms is useful for determining the correct code in some cases, but the list is not necessarily exhaustive.
- Hyperplasia of pancreatic endocrine cells with glucagon excess
- DRG Group #643-645 - Endocrine disorders with MCC.
- DRG Group #643-645 - Endocrine disorders with CC.
- DRG Group #643-645 - Endocrine disorders without CC or MCC.
ICD-10-CM Alphabetical Index References for 'E16.3 - Increased secretion of glucagon'
The ICD-10-CM Alphabetical Index links the below-listed medical terms to the ICD code E16.3. Click on any term below to browse the alphabetical index.
Equivalent ICD-9 Code GENERAL EQUIVALENCE MAPPINGS (GEM)
Abnormality of secretion of glucagon (exact match)
This is the official exact match mapping between ICD9 and ICD10, as provided by the General Equivalency mapping crosswalk. This means that in all cases where the ICD9 code 251.4 was previously used, E16.3 is the appropriate modern ICD10 code.
Parent Code: E16 - Other disorders of pancreatic internal secretion